1. Home
  2. Analysis
  3. Nexavar
  4. Xylocaine

Nexavar and Xylocaine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nexavar and Xylocaine. Common interactions include abdominal discomfort among females and hypertension among males.

The phase IV clinical study analyzes what interactions people who take Nexavar and Xylocaine have. It is created by eHealthMe based on reports of 9 people who take Nexavar and Xylocaine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 28, 2023

9 people who take Nexavar and Xylocaine together, and have interactions are studied.

What is Nexavar?

Nexavar has active ingredients of sorafenib tosylate. It is often used in hepatocellular carcinoma. eHealthMe is studying from 22,624 Nexavar users for its effectiveness, alternative drugs and more.

What is Xylocaine?

Xylocaine has active ingredients of lidocaine hydrochloride. eHealthMe is studying from 5,700 Xylocaine users for its effectiveness, alternative drugs and more.

Number of Nexavar and Xylocaine reports submitted per year:

Nexavar and Xylocaine drug interactions.

Common Nexavar and Xylocaine drug interactions by gender *:

female:

  1. Abdominal discomfort
  2. Alopecia
  3. Anaemia
  4. Back pain
  5. Erythema
  6. Headache
  7. Hypoaesthesia
  8. Neuralgia
  9. Pain in extremity
  10. Palmar-plantar erythrodysaesthesia syndrome

male:

  1. Hypertension
  2. Pleural effusion
  3. Hypoalbuminaemia
  4. Renal failure
  5. Respiratory failure
  6. Anaemia
  7. Acidosis
  8. Convulsion
  9. Face oedema
  10. Hypoglycaemia

Common Nexavar and Xylocaine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal discomfort
  2. Alopecia
  3. Anaemia
  4. Back pain
  5. Erythema
  6. Headache
  7. Hypoaesthesia
  8. Neuralgia
  9. Pain in extremity
  10. Palmar-plantar erythrodysaesthesia syndrome

60+:

  1. Hypertension
  2. Pleural effusion
  3. Hypoalbuminaemia
  4. Renal failure
  5. Respiratory failure
  6. Anaemia
  7. Acidosis
  8. Convulsion
  9. Face oedema
  10. Hypoglycaemia

* Approximation only. Some reports may have incomplete information.

Do you take Nexavar and Xylocaine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Nexavar and Xylocaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nexavar side effects:

Browse all side effects of Nexavar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xylocaine side effects:

Browse all side effects of Xylocaine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nexavar interactions:

Browse all interactions between Nexavar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xylocaine interactions:

Browse all interactions between Xylocaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sorafenib tosylate and lidocaine hydrochloride (the active ingredients of Nexavar and Xylocaine, respectively), and Nexavar and Xylocaine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Nexavar and Xylocaine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.